hu.MAP 3.0: Complex View
Human Protein Complex Map
Search for a protein
Complex: huMAP3_11257.1
Complex Portal: CPX-16629
Confidence: Medium  
Proteins| Genename | Protein Name | Uniprot Annotation Score | Links |
|---|---|---|---|
| RCAN1 | Calcipressin-1 (Adapt78) (Down syndrome critical region protein 1) (Myocyte-enriched calcineurin-interacting protein 1) (MCIP1) (Regulator of calcineurin 1) | 5 | UniProt   NCBI |
| AXIN2 | Axin-2 (Axin-like protein) (Axil) (Axis inhibition protein 2) (Conductin) | 5 | UniProt   NCBI |
| GSKIP | GSK3B-interacting protein (GSKIP) (GSK3beta interaction protein) | 5 | UniProt   NCBI |
| GSK3A | Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1) | 5 | UniProt   NCBI |
| FRAT2 | GSK-3-binding protein FRAT2 (Frequently rearranged in advanced T-cell lymphomas 2) (FRAT-2) | 3 | UniProt   NCBI |
| GSK3B | Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1) | 5 | UniProt   NCBI |
| FRAT1 | Proto-oncogene FRAT1 (Frequently rearranged in advanced T-cell lymphomas 1) (FRAT-1) | 5 | UniProt   NCBI |
| RILPL2 | RILP-like protein 2 (Rab-interacting lysosomal protein-like 2) (p40phox-binding protein) | 5 | UniProt   NCBI |
| CATSPER2 | Cation channel sperm-associated protein 2 (CatSper2) | 5 | UniProt   NCBI |
| AXIN1 | Axin-1 (Axis inhibition protein 1) (hAxin) | 5 | UniProt   NCBI |
Enrichments
| Term ID | Corrected Pval | Fraction Complex Coverage | Proteins | Term Name |
|---|---|---|---|---|
|   REAC:R-HSA-196299 | 6.32607926503e-08 | 0.4 | FRAT2 AXIN1 FRAT1 GSK3B | Beta-catenin phosphorylation cascade |
|   WP:WP4258 | 1.26830251876e-07 | 0.5 | AXIN2 AXIN1 GSK3B FRAT1 FRAT2 | lncRNA in canonical Wnt signaling and colorectal cancer |
|   KEGG:05224 | 5.61017394541e-07 | 0.5 | AXIN2 AXIN1 GSK3B FRAT1 FRAT2 | Breast cancer |
|   GO:0060070 | 5.98064921821e-07 | 0.7 | FRAT2 AXIN2 FRAT1 AXIN1 GSKIP GSK3B GSK3A | canonical Wnt signaling pathway |
|   KEGG:05226 | 6.55971078187e-07 | 0.5 | AXIN2 AXIN1 GSK3B FRAT1 FRAT2 | Gastric cancer |
|   REAC:R-HSA-4641262 | 8.32503276128e-07 | 0.4 | FRAT2 AXIN1 FRAT1 GSK3B | Disassembly of the destruction complex and recruitment of AXIN to the membrane |
|   KEGG:04310 | 1.29689944557e-06 | 0.5 | AXIN2 AXIN1 GSK3B FRAT1 FRAT2 | Wnt signaling pathway |
|   WP:WP4262 | 1.38398941122e-06 | 0.5 | AXIN2 AXIN1 GSK3B FRAT1 FRAT2 | Breast cancer pathway |
|   WP:WP363 | 1.59895364063e-06 | 0.4 | GSK3A AXIN1 FRAT1 GSK3B | Wnt signaling pathway |
|   KEGG:05225 | 1.73773564836e-06 | 0.5 | AXIN2 AXIN1 GSK3B FRAT1 FRAT2 | Hepatocellular carcinoma |
|   GO:0030877 | 1.81927560642e-06 | 0.4 | AXIN2 AXIN1 GSK3B GSK3A | beta-catenin destruction complex |
|   GO:0016055 | 5.54953663704e-06 | 0.7 | FRAT2 AXIN2 FRAT1 AXIN1 GSKIP GSK3B GSK3A | Wnt signaling pathway |
|   GO:0198738 | 6.1222538852e-06 | 0.7 | FRAT2 AXIN2 FRAT1 AXIN1 GSKIP GSK3B GSK3A | cell-cell signaling by wnt |
|   WP:WP4872 | 8.23219900182e-06 | 0.3 | GSK3B FRAT1 AXIN1 | MAP3K1 role in promoting and blocking gonadal determination |
|   WP:WP4336 | 1.22306700697e-05 | 0.4 | FRAT2 AXIN1 FRAT1 GSK3B | ncRNAs involved in Wnt signaling in hepatocellular carcinoma |
|   GO:0060828 | 1.98346738234e-05 | 0.6 | AXIN2 FRAT1 AXIN1 GSKIP GSK3B GSK3A | regulation of canonical Wnt signaling pathway |
|   WP:WP5124 | 2.19679744334e-05 | 0.5 | AXIN2 AXIN1 GSK3B FRAT1 FRAT2 | Alzheimer 39 s disease |
|   WP:WP2059 | 2.19679744334e-05 | 0.5 | AXIN2 AXIN1 GSK3B FRAT1 FRAT2 | Alzheimer 39 s disease and miRNA effects |
|   CORUM:7128 | 3.07577115383e-05 | 0.2 | GSK3B GSKIP | GSKIP-GSK3B-PRKAR2A complex |
|   CORUM:7127 | 3.07577115383e-05 | 0.2 | GSK3B GSKIP | GSKIP-GSK3B-PRKAR2A complex |
|   REAC:R-HSA-201681 | 3.12083180803e-05 | 0.5 | AXIN2 AXIN1 GSK3B FRAT1 FRAT2 | TCF dependent signaling in response to WNT |
|   WP:WP399 | 3.22018663705e-05 | 0.4 | AXIN2 AXIN1 FRAT1 GSK3B | Wnt signaling pathway and pluripotency |
|   WP:WP428 | 4.30150812668e-05 | 0.4 | FRAT2 AXIN1 FRAT1 GSK3B | Wnt signaling |
|   REAC:R-HSA-195253 | 4.33004932357e-05 | 0.4 | FRAT2 AXIN1 FRAT1 GSK3B | Degradation of beta-catenin by the destruction complex |
|   GO:1904886 | 4.61210427592e-05 | 0.3 | FRAT2 FRAT1 GSK3B | beta-catenin destruction complex disassembly |
|   KEGG:05010 | 7.62846862374e-05 | 0.5 | AXIN2 AXIN1 GSK3B FRAT1 FRAT2 | Alzheimer disease |
|   CORUM:6352 | 9.22394575203e-05 | 0.2 | GSK3B AXIN1 | FoxM1-Axin-GSK3beta complex |
|   CORUM:6353 | 9.22394575203e-05 | 0.2 | GSK3B AXIN1 | beta-Catenin destruction complex |
|   CORUM:6963 | 9.22394575203e-05 | 0.2 | GSK3B AXIN1 | AXIN1-GID8-GSK3B complex |
|   CORUM:7130 | 9.22394575203e-05 | 0.2 | GSK3B GSKIP | PRKAR2A-GSKIP-GSK3B-DNM1L complex |
|   CORUM:3166 | 9.22394575203e-05 | 0.2 | GSK3B AXIN1 | AXIN1-APC-CTNNB1-GSK3B complex |
|   GO:0030111 | 0.00011153855885 | 0.6 | AXIN2 FRAT1 AXIN1 GSKIP GSK3B GSK3A | regulation of Wnt signaling pathway |
|   CORUM:7159 | 0.000184411585051 | 0.2 | GSK3B AXIN1 | TSC2-GSK3-AXIN-DVL complex |
|   CORUM:4151 | 0.000184411585051 | 0.2 | GSK3B AXIN1 | TSC (TSC1, TSC2, AXIN, GSK3) complex |
|   CORUM:2998 | 0.000184411585051 | 0.2 | GSK3B AXIN1 | Axin-PP2A A-PP2A C-GSK3-beta-beta-catenin complex |
|   REAC:R-HSA-195721 | 0.000187650116668 | 0.5 | AXIN2 AXIN1 GSK3B FRAT1 FRAT2 | Signaling by WNT |
|   KEGG:05022 | 0.000200911474306 | 0.5 | AXIN2 AXIN1 GSK3B FRAT1 FRAT2 | Pathways of neurodegeneration - multiple diseases |
|   KEGG:05213 | 0.00025222334173 | 0.3 | AXIN2 AXIN1 GSK3B | Endometrial cancer |
|   KEGG:05200 | 0.000289324227938 | 0.5 | AXIN2 AXIN1 GSK3B FRAT1 FRAT2 | Pathways in cancer |
|   KEGG:05217 | 0.00029909224236 | 0.3 | AXIN2 AXIN1 GSK3B | Basal cell carcinoma |
|   WP:WP4155 | 0.00065158533309 | 0.3 | AXIN2 AXIN1 GSK3B | Endometrial cancer |
|   KEGG:05210 | 0.000860152101115 | 0.3 | AXIN2 AXIN1 GSK3B | Colorectal cancer |
|   WP:WP4216 | 0.00106295369076 | 0.3 | AXIN2 AXIN1 GSK3B | Chromosomal and microsatellite instability in colorectal cancer |
|   WP:WP2064 | 0.00143474462389 | 0.3 | AXIN2 AXIN1 GSK3B | Neural crest differentiation |
|   KEGG:04550 | 0.00312760944256 | 0.3 | AXIN2 AXIN1 GSK3B | Signaling pathways regulating pluripotency of stem cells |
|   KEGG:04934 | 0.00353228654663 | 0.3 | AXIN2 AXIN1 GSK3B | Cushing syndrome |
|   WP:WP710 | 0.00365274550904 | 0.3 | GSK3B FRAT1 AXIN1 | DNA damage response only ATM dependent |
|   REAC:R-HSA-9683610 | 0.0036548283771 | 0.2 | GSK3A GSK3B | Maturation of nucleoprotein |
|   WP:WP3664 | 0.0049515659161 | 0.2 | GSK3B AXIN1 | Regulation of Wnt B catenin signaling by small molecule compounds |
|   GO:0032436 | 0.00495760415907 | 0.4 | AXIN2 AXIN1 GSK3B GSK3A | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
|   KEGG:04390 | 0.00560546698078 | 0.3 | AXIN2 AXIN1 GSK3B | Hippo signaling pathway |
|   WP:WP3872 | 0.00704825789595 | 0.2 | GSK3A GSK3B | Regulation of apoptosis by parathyroid hormone related protein |
|   WP:WP5087 | 0.0075599887011 | 0.4 | FRAT2 AXIN1 FRAT1 GSK3B | Pleural mesothelioma |
|   REAC:R-HSA-9694631 | 0.00790724004214 | 0.2 | GSK3A GSK3B | Maturation of nucleoprotein |
|   REAC:R-HSA-198323 | 0.00790724004214 | 0.2 | GSK3A GSK3B | AKT phosphorylates targets in the cytosol |
|   REAC:R-HSA-4839744 | 0.00922174626729 | 0.2 | GSK3B AXIN1 | Signaling by APC mutants |
|   REAC:R-HSA-4839748 | 0.00922174626729 | 0.2 | GSK3B AXIN1 | Signaling by AMER1 mutants |
|   REAC:R-HSA-5467348 | 0.00922174626729 | 0.2 | GSK3B AXIN1 | Truncations of AMER1 destabilize the destruction complex |
|   REAC:R-HSA-4839735 | 0.00922174626729 | 0.2 | GSK3B AXIN1 | Signaling by AXIN mutants |
|   REAC:R-HSA-5467340 | 0.00922174626729 | 0.2 | GSK3B AXIN1 | AXIN missense mutants destabilize the destruction complex |
|   REAC:R-HSA-5467337 | 0.00922174626729 | 0.2 | GSK3B AXIN1 | APC truncation mutants have impaired AXIN binding |
|   WP:WP2583 | 0.00951090854291 | 0.2 | GSK3A GSK3B | T cell receptor and co stimulatory signaling |
|   GO:2000060 | 0.0103846818546 | 0.4 | AXIN2 AXIN1 GSK3B GSK3A | positive regulation of ubiquitin-dependent protein catabolic process |
|   REAC:R-HSA-4839743 | 0.0106365927257 | 0.2 | GSK3B AXIN1 | Signaling by CTNNB1 phospho-site mutants |
|   REAC:R-HSA-5358747 | 0.0106365927257 | 0.2 | GSK3B AXIN1 | CTNNB1 S33 mutants aren't phosphorylated |
|   REAC:R-HSA-5358749 | 0.0106365927257 | 0.2 | GSK3B AXIN1 | CTNNB1 S37 mutants aren't phosphorylated |
|   REAC:R-HSA-5358751 | 0.0106365927257 | 0.2 | GSK3B AXIN1 | CTNNB1 S45 mutants aren't phosphorylated |
|   REAC:R-HSA-5358752 | 0.0106365927257 | 0.2 | GSK3B AXIN1 | CTNNB1 T41 mutants aren't phosphorylated |
|   REAC:R-HSA-5339716 | 0.0106365927257 | 0.2 | GSK3B AXIN1 | Signaling by GSK3beta mutants |
|   WP:WP3658 | 0.0113553886492 | 0.2 | AXIN2 GSK3B | Wnt beta catenin signaling pathway in leukemia |
|   GO:1901800 | 0.0137249930817 | 0.4 | AXIN2 AXIN1 GSK3B GSK3A | positive regulation of proteasomal protein catabolic process |
|   GO:0090090 | 0.0149986773182 | 0.4 | AXIN2 AXIN1 GSK3B GSK3A | negative regulation of canonical Wnt signaling pathway |
|   GO:0046825 | 0.0176420810956 | 0.3 | FRAT2 FRAT1 GSK3B | regulation of protein export from nucleus |
|   WP:WP4844 | 0.0178579187559 | 0.2 | GSK3B AXIN1 | Influence of laminopathies on Wnt signaling |
|   WP:WP127 | 0.0190825311458 | 0.2 | GSK3A GSK3B | IL 5 signaling pathway |
|   GO:2000077 | 0.0210690324038 | 0.2 | GSK3A GSK3B | negative regulation of type B pancreatic cell development |
|   GO:0007267 | 0.0220289791766 | 0.7 | FRAT2 AXIN2 FRAT1 AXIN1 GSKIP GSK3B GSK3A | cell-cell signaling |
|   GO:1903052 | 0.0255498654968 | 0.4 | AXIN2 AXIN1 GSK3B GSK3A | positive regulation of proteolysis involved in protein catabolic process |
|   WP:WP500 | 0.0272713027679 | 0.2 | GSK3A GSK3B | Glycogen synthesis and degradation |
|   GO:0032434 | 0.028615496869 | 0.4 | AXIN2 AXIN1 GSK3B GSK3A | regulation of proteasomal ubiquitin-dependent protein catabolic process |
|   REAC:R-HSA-5674400 | 0.0302795201711 | 0.2 | GSK3A GSK3B | Constitutive Signaling by AKT1 E17K in Cancer |
|   REAC:R-HSA-9683701 | 0.032790839879 | 0.2 | GSK3A GSK3B | Translation of Structural Proteins |
|   GO:0030178 | 0.0368293644996 | 0.4 | AXIN2 AXIN1 GSK3B GSK3A | negative regulation of Wnt signaling pathway |
|   KEGG:05165 | 0.0438405134702 | 0.3 | AXIN2 AXIN1 GSK3B | Human papillomavirus infection |
|   WP:WP4879 | 0.0441033585523 | 0.2 | GSK3B AXIN1 | Overlap between signal transduction pathways contributing to LMNA laminopathies |
Edges
| Protein 1 | Protein 2 | Score | ProteomeHD | Interface Overlap | Evidence |
|---|---|---|---|---|---|
|  GSK3A |  GSK3B | 1.0 | 0.196           |          | hein_WMM     bioplex3_HEK293     bioplex_WMM     bioplex3_WMM     youn_WMM     fraction     |
|  GSK3A |  RCAN1 | 0.999 | 0.184           |          | bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     bioplex3_HCT116     |
|  GSK3A |  FRAT1 | 0.999 |            |
structurally_consistent (dimer)        
|
hein_WMM     bioplex3_HEK293     bioplex3_WMM     hein ()     bioplex3_HCT116     |
|  FRAT2 |  RILPL2 | 0.999 |            |          | bioplex3_HEK293     bioplex3_WMM     bioplex3_HCT116     WMM_only     |
|  GSKIP |  GSK3A | 0.999 | 0.09           |
structurally_consistent (dimer)        
|
bioplex3_HEK293     bioplex3_WMM     bioplex3_HCT116     WMM_only     |
|  GSK3A |  AXIN1 | 0.998 | 0.23           |          | hein_WMM     bioplex3_HEK293     bioplex3_WMM     hein ()     bioplex3_HCT116     |
|  GSK3A |  FRAT2 | 0.997 |            |
structurally_consistent (dimer)        
|
bioplex3_HEK293     bioplex3_WMM     bioplex3_HCT116     WMM_only     |
|  GSKIP |  GSK3B | 0.997 | 0.136           |          | bioplex3_HEK293     bioplex3_WMM     bioplex3_HCT116     WMM_only     |
|  AXIN2 |  GSK3A | 0.997 |            |          | bioplex3_HEK293     bioplex3_WMM     bioplex3_HCT116     WMM_only     |
|  GSK3B |  FRAT2 | 0.996 |            |          | bioplex3_HEK293     bioplex3_WMM     bioplex3_HCT116     WMM_only     |
|  GSK3B |  RCAN1 | 0.996 | 0.088           |          | bioplex3_HEK293     bioplex ()     bioplex_WMM     bioplex3_WMM     bioplex3_HCT116     |
|  GSK3B |  AXIN1 | 0.995 | 0.256           |          | hein_WMM     bioplex3_WMM     hein ()     gupta_WMM     |
|  AXIN2 |  GSK3B | 0.992 |            |          | bioplex3_HEK293     bioplex3_WMM     bioplex3_HCT116     WMM_only     |
|  GSK3B |  FRAT1 | 0.992 |            |          | hein_WMM     bioplex3_WMM     hein ()     |
|  FRAT1 |  AXIN1 | 0.946 |            |          | bioplex3_WMM     WMM_only     |
|  AXIN2 |  FRAT1 | 0.946 |            |          | bioplex3_WMM     WMM_only     |
|  AXIN2 |  AXIN1 | 0.946 |            |          | bioplex3_WMM     WMM_only     |
|  RCAN1 |  CATSPER2 | 0.928 |            |          | bioplex3_HEK293     bioplex3_WMM     WMM_only     |
|  FRAT1 |  RCAN1 | 0.905 |            |          | bioplex3_WMM     WMM_only     |
|  GSK3A |  RILPL2 | 0.874 | 0.106           |          | bioplex3_WMM     WMM_only     |
|  GSKIP |  FRAT1 | 0.792 |            |
mutually_exclusive (P49840)        
|
bioplex3_WMM     WMM_only     |
|  GSKIP |  AXIN1 | 0.757 | 0.212           |          | bioplex3_WMM     WMM_only     |
|  AXIN1 |  RCAN1 | 0.757 | 0.267333333333           |          | bioplex3_WMM     WMM_only     |
|  GSK3B |  RILPL2 | 0.74 | 0.038           |          | bioplex3_WMM     WMM_only     |
|  AXIN2 |  RCAN1 | 0.49 |            |          | bioplex3_WMM     WMM_only     |
|  GSKIP |  RCAN1 | 0.467 | 0.134           |          | bioplex3_WMM     WMM_only     |
|  AXIN2 |  GSKIP | 0.466 |            |          | bioplex3_WMM     WMM_only     |
|  AXIN2 |  FRAT2 | 0.274 |            |          | bioplex3_WMM     WMM_only     |
|  AXIN1 |  FRAT2 | 0.25 |            |          | bioplex3_WMM     WMM_only     |
|  FRAT1 |  FRAT2 | 0.135 |            |
mutually_exclusive (P49840)        
|
bioplex3_WMM     WMM_only     |
|  FRAT2 |  RCAN1 | 0.078 |            |          | bioplex3_WMM     WMM_only     |
|  GSKIP |  FRAT2 | 0.078 |            |
mutually_exclusive (P49840)        
|
bioplex3_WMM     WMM_only     |
Related Complexes